|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-16.38/-3.58
|
企业价值
121.54M
|
资产负债 |
每股账面净值
1.47
|
现金流量 |
现金流量率
--
|
损益表 |
收益
0
|
每股收益
--
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/12/24 12:21 EST
同行比较之报价最少15分钟延迟
业务概览
|
|||
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indicationsas graft-versus-host disease (GvHD), vitiligo, and alopecia areata (AA). |